Research
Clinical research, regulatory updates, and patient education from TelosRX, an online-first telehealth service.
Microdosing GLP-1 for Autoimmune Disease: The Evidence
Microdosing GLP-1 for autoimmune disease reviewed: early findings in lupus, RA, psoriasis and MS, and why no microdose studies have been published yet.
Microdosing Ozempic: Why Click Charts Fail
Microdosing Ozempic explained: why the pen label warns against counting clicks, what it means for Wegovy, and how a provider sets a lower dose safely.
Microdosing Zepbound: What the Label Allows
Microdosing Zepbound explained: what the labels say about fixed-dose pens and KwikPens, why partial dosing is risky, and how lower doses are prescribed.
Microdosing GLP-1 for PCOS: What Research Shows
Microdosing GLP-1 for PCOS reviewed: what standard-dose studies found, where microdose data are missing, and fertility points to raise with your clinician.
Microdosing Tirzepatide Not Working? 7 Common Reasons
Microdosing tirzepatide not working? Here are the common reasons, why the scale can rise on a low dose, and what to ask your provider before changing...
Semaglutide Maintenance Dose: What the Label Says
Semaglutide maintenance dose explained: what the Wegovy label says, what happens if you stop, and what research says about lower doses after weight loss.
GLP-1 Receptor Agonists, Answered: Top Questions
What is a GLP-1 receptor agonist? Our clinical team answers the top questions on how they work, FDA-approved brands, side effects and safety.
Oral Microdosing GLP-1: Pills, Drops and Sublingual
Oral microdosing GLP-1 sounds simple, but tablet labels forbid splitting and compounded drops have little data. See what exists and what is still unknown.
Microdosing GLP-1 Before and After: An Honest Look
Microdosing GLP-1 before and after posts are everywhere, but research on sub-label doses is thin. Learn why photos mislead and how to judge results honestly.
Microdosing Tirzepatide Twice a Week: What to Know
Microdosing tirzepatide twice a week is off-label. See what the FDA label says about weekly dosing and half-life, and why your provider sets the schedule.
Microdosing GLP-1 and Hair Loss: What Research Shows
Microdosing GLP-1 and hair loss: labels link shedding to weight reduction, but no study has tested sub-label doses. See what the evidence does and does not...
Is Microdosing GLP-1 Safe? Risks and Long-Term Questions
Is microdosing GLP-1 safe? Lower doses may ease side effects, but long-term data are thin and label warnings still apply. Here is what is known and...
Microdosing Semaglutide Dosage Chart: What to Know
A microdosing semaglutide dosage chart from the internet is not a safe guide. See what the FDA label says, why units vary, and who should set...
Microdosing GLP-1 for Perimenopause: What Research Shows
Microdosing GLP-1 for perimenopause has almost no direct research. See what midlife studies found, the gaps, and the safety points worth raising first.
Microdosing Tirzepatide Cost: What You Pay and Why
Microdosing tirzepatide cost varies by provider. See what a fair price includes, how insurance works, and what telos rx lists as of publication.
Tirzepatide Maintenance Dose: What the Label Says
The tirzepatide maintenance dose is set by your prescriber. Learn what the Zepbound label lists, what research found, and where microdosing fits.
Microdosing GLP-1 for Inflammation: What Research Shows
Microdosing GLP-1 for inflammation has no direct trial data. Here is what standard-dose studies found on markers like CRP, and what remains unknown.
Cagrilintide vs Retatrutide, Answered: Top Questions
Cagrilintide vs retatrutide, answered: how the amylin and triple-agonist drugs differ, what the trials show, and why neither one is FDA-approved yet.
Microdosing Tirzepatide Dosage Chart: What to Know
A microdosing tirzepatide dosage chart cannot fit everyone. Learn what the FDA label says, why unit charts mislead, and who should set your dose instead.
Microdosing GLP-1 for Menopause: What Research Shows
Microdosing GLP-1 for menopause has little direct research. See what standard-dose studies found, the gaps, and how HRT and weight goals fit together.
Microdosing Tirzepatide for Weight Loss: What to Know
Microdosing tirzepatide for weight loss explained: what research measured at labeled doses, what is unknown about lower doses, and how providers decide.
Does Microdosing Tirzepatide Work? What Research Shows
Does microdosing tirzepatide work? No controlled trials have tested sub-label doses yet. Here is what the label and research show, and what is still unknown.
Retatrutide Knee Osteoarthritis: What the Research Shows
Retatrutide knee osteoarthritis trials reported less knee pain and large weight changes versus placebo. Here's what TRIUMPH-4 found and what it can't show.
How Long Has Semaglutide Been Around? What Research Shows
How long has semaglutide been around? Since its 2017 Ozempic approval, with GLP-1 research dating to the 1980s. See the cited trial timeline from TelosRX.
918 articles in GLP-1 & Weight Loss